Founded by a group of physicians, CERC has a wide experience in clinical research. Their renown and expertise in this field have enabled them to generate optimal interaction with their industrial partners and other medical research teams focusing on the development of innovative techniques, concepts and treatments.
They provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularisation, structural and valvular heart disease treatments and adjunctive pharmacology.
Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
The CERC’s industrial partners attach great importance to finding cost-effective models which do not compromise quality.
Learn more: www.cerc-europe.org
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
May 27, 2025
24 June 2025 – 8:00 AM (CET) Join our upcoming webinar in collaboration with PharmaLex to explore current challenges in clinical trials for targeted therapies. We’ll discuss how eClinical solutions can optimize processes—from managing complex data to coordinating stakeholders and enabling real-time decision-making. This interactive session is designed for industry professionals at the intersection of […]
May 27, 2025
28 May 2025 – 04:00 PM to 05:00 PM CET (Webinar) Yoanni Th. Matsakis, President of Telemedicine Technologies, attends the first xShare webinar on the EHDS Adoption Kit for citizens. The event introduces the European Health Data Space (EHDS) and the European Electronic Health Record Exchange Format (EEHRxF). It explores data-driven healthcare through “The Health […]
May 27, 2025
Med City News Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. In the life sciences community, there’s a […]